Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

This study has been completed.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 10, 2007
Last updated: February 11, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)